Dr. Peter McSweeney, MD
Claim this profileColorado Blood Cancer Institute
Area of expertise
Multiple Myeloma
Peter McSweeney, MD has run 3 trials for Multiple Myeloma. Some of their research focus areas include:
Acute Lymphoblastic Leukemia
Peter McSweeney, MD has run 3 trials for Acute Lymphoblastic Leukemia. Some of their research focus areas include:
Affiliated Hospitals
Colorado Blood Cancer Institute
Rocky Mountain Blood And Marrow Transplant Program
Clinical Trials Peter McSweeney, MD is currently running
Unlicensed Cord Blood Transplant
for Blood/Immune System Disorders
This trial is testing the safety of giving patients special blood from umbilical cords. The study focuses on patients who receive these infusions to see if there are any serious side effects. The cord blood has special cells that can help make new blood cells in the body. Umbilical cord blood has been used in the treatment of various diseases for many years, including leukemia, lymphoma, and congenital immunodeficiency.
Recruiting
1 award
Phase 2
1 criteria
Cord Blood Units
for Blood Cancers
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
Recruiting
1 award
N/A
3 criteria
More about Peter McSweeney, MD
Clinical Trial Related
8 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Peter McSweeney, MD has experience with
- Dexamethasone
- Elotuzumab
- Pomalidomide
- NKX019
- MMF
- Tacrolimus
Breakdown of trials Peter McSweeney, MD has run
Multiple Myeloma
Acute Lymphoblastic Leukemia
Non-Hodgkin's Lymphoma
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter McSweeney, MD specialize in?
Peter McSweeney, MD focuses on Multiple Myeloma and Acute Lymphoblastic Leukemia. In particular, much of their work with Multiple Myeloma has involved Stage IV patients, or patients who are undergoing treatment.
Is Peter McSweeney, MD currently recruiting for clinical trials?
Yes, Peter McSweeney, MD is currently recruiting for 2 clinical trials in Denver Colorado. If you're interested in participating, you should apply.
Are there any treatments that Peter McSweeney, MD has studied deeply?
Yes, Peter McSweeney, MD has studied treatments such as Dexamethasone, Elotuzumab, Pomalidomide.
What is the best way to schedule an appointment with Peter McSweeney, MD?
Apply for one of the trials that Peter McSweeney, MD is conducting.
What is the office address of Peter McSweeney, MD?
The office of Peter McSweeney, MD is located at: Colorado Blood Cancer Institute, Denver, Colorado 80218 United States. This is the address for their practice at the Colorado Blood Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.